Back to FMR LLC

SYRE
6 quarters

Position history for FMR LLC's holdings in SPYRE THERAPEUTICS INC

FMR LLC holds 11.8M shares of SYRE (SPYRE THERAPEUTICS INC), worth $594.2M as of 2026-Q1. The position was increased (+1.2% shares). SYRE represents 0.0% of FMR LLC's portfolio.

Current Value

$594.2M

Current Shares

11.8M

Total Value Change

+$389.3M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
11.8M
+1.2%
$594.2M0.0%$40.07
32
2025-Q4
Increased
11.6M
+28.5%
$381.3M0.0%$31.88
39
2025-Q3
Increased
9.1M
+0.1%
$151.8M0.0%$16.36
30
2025-Q2
Increased
9.1M
+0.2%
$135.5M0.0%$15.22
30
2025-Q1
Increased
9M
+2.7%
$145.8M0.0%$17.94
31
2024-Q4
New
8.8M
-
$204.9M0.0%$22.54
42

Other major holders of SYRE: BlackRock, Inc., RTW INVESTMENTS, LP, VANGUARD CAPITAL MANAGEMENT LLC, DRIEHAUS CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used